Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 11

1.

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.

Rossi G, Marchioni A, Milani M, Scotti R, Foroni M, Cesinaro A, Longo L, Migaldi M, Cavazza A.

Am J Clin Pathol. 2004 Dec;122(6):884-93.

PMID:
15595193
2.

Expression of cytokeratin 34βE12 is a good indicator of tumor progression in esophageal squamous cell carcinoma.

Ono M, Kijima H, Seino H, Hakamada K, Igarashi Y.

Biomed Res. 2012 Jun;33(3):183-9.

3.
4.
6.

34betaE12 Cytokeratin Immunodetection in the Differential Diagnosis of Small Cell Tumors of Lung.

Viberti L, Bongiovanni M, Croce S, Bussolati G.

Int J Surg Pathol. 2000 Oct;8(4):317-322.

PMID:
11494008
7.

Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast.

Mehta R, Jain RK, Sneige N, Badve S, Resetkova E.

J Clin Pathol. 2010 Aug;63(8):744-7. doi: 10.1136/jcp.2010.076653.

PMID:
20702478
9.

34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast.

Papotti M, Sapino A, Righi L, Chiappone S, Bussolati G.

Appl Immunohistochem Mol Morphol. 2001 Sep;9(3):229-33.

PMID:
11556750
11.

High-molecular-weight cytokeratin antibody (clone 34betaE12) as a urothelial marker: a note of caution.

Varma M, Morgan M, Amin MB, Wozniak S, Jasani B.

Histopathology. 2004 Feb;44(2):189-90. No abstract available.

PMID:
14764064

Supplemental Content

Support Center